Transcode Therapeutics, INC. (RNAZ) SEC Filings — 2024
41 SEC filings for Transcode Therapeutics, INC. (RNAZ) in 2024.
Filings
- Transcode Therapeutics Files Definitive Proxy Statement — DEF 14A · Dec 30, 2024
- Transcode Therapeutics Files 8-K — 8-K · Dec 20, 2024
- Transcode Therapeutics Files S-1 for Public Offering — S-1 · Dec 6, 2024
- Transcode Therapeutics Files 8-K: Material Agreement & Equity Sales — 8-K · Dec 2, 2024
- Transcode Therapeutics Files 8-K on Security Holder Rights — 8-K · Nov 29, 2024
- Transcode Therapeutics Files 8-K on Shareholder Vote Matters — 8-K · Nov 25, 2024
- Transcode Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 14, 2024
- TransCode Therapeutics Seeks Shareholder Approval for Reverse Stock Split — DEFA14A · Nov 13, 2024
- Transcode Therapeutics Faces Delisting Concerns — 8-K · Nov 6, 2024
- Transcode Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Nov 6, 2024
- TransCode Therapeutics Files Proxy Statement for Annual Meeting — DEF 14A · Oct 28, 2024
- Transcode Therapeutics Faces Delisting Concerns — 8-K · Sep 27, 2024
- Transcode Therapeutics to be Acquired by 03 Life Sciences — 8-K · Aug 28, 2024
- Transcode Therapeutics Faces Delisting Notice — 8-K · Aug 16, 2024
- Transcode Therapeutics Q2 2024 Update — 10-Q · Aug 14, 2024
- Transcode Therapeutics, INC. SC 13G Filing — SC 13G · Jul 26, 2024
- Transcode Therapeutics Files 8-K: Material Agreement & Equity Sales — 8-K · Jul 24, 2024
- Fitzgerald Files SC 13D for Transcode Therapeutics — SC 13D · Jun 21, 2024
- TransCode Therapeutics Corrects Shareholder Meeting Vote Results — 8-K/A · Jun 14, 2024
- TransCode Therapeutics Files 8-K on Shareholder Votes — 8-K · Jun 13, 2024
- TransCode Therapeutics Regains Nasdaq Listing Compliance — DEFA14A · Jun 10, 2024
- Transcode Therapeutics to be Acquired by 03 Life Sciences — 8-K · Jun 7, 2024
- 180 Life Sciences to Acquire Transcode Therapeutics — 8-K · May 15, 2024
- Transcode Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 15, 2024
- TransCode Therapeutics Seeks Shareholder Vote on Reverse Stock Split — DEFA14A · May 13, 2024
- Transcode Therapeutics Faces Listing Rule Issues — 8-K · May 10, 2024
- Transcode Therapeutics Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 29, 2024
- Transcode Therapeutics Files 8-K on Shareholder Nominations — 8-K · Apr 23, 2024
- Transcode Therapeutics Files 8-K on Financials — 8-K · Apr 5, 2024
- Transcode Therapeutics Files 2023 Annual Report on Form 10-K — 10-K · Apr 1, 2024
- Transcode Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 15, 2024
- Transcode Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Transcode Therapeutics, INC. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Transcode Therapeutics Files 8-K for Major Corporate Action — 8-K · Jan 31, 2024
- RNAZ Raises $4M via Stock Offering & Private Placement — 8-K · Jan 22, 2024
- Transcode Therapeutics Files Amendment to S-1 Registration Statement — S-1/A · Jan 18, 2024
- Transcode Therapeutics Files Amendment to S-1 Registration Statement — S-1/A · Jan 17, 2024
- Transcode Therapeutics 8-K Hints at Major Governance, Rights Changes — 8-K · Jan 16, 2024
- Transcode Therapeutics Files S-1 for Potential Public Offering — S-1 · Jan 11, 2024
- RNAZ Files 8-K on Shareholder Vote Submission — 8-K · Jan 8, 2024
- TransCode Therapeutics Details 2023 Progress, 2024 Objectives in Shareholder Letter — DEFA14A · Jan 4, 2024